SFigure 1 from Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors
Weicai Chen(East China University of Science and Technology), Wen‐Bin Ou(Zhejiang Sci-Tech University), Yuqing Tu, Haibo Qiu(Zhongda Hospital Southeast University), Mei‐Jun Zhu(Washington State University), Ye Chow Kuang, Zhifa Cao(Tongji University), Grant Eilers(Brigham and Women's Hospital), Hailong Li, Rongqing Zhang(Jiaxing University), Yeqing Wu, Yuexiang Wang(Shanghai Institute of Nutrition and Health), Jonathan A. Fletcher(Harvard University), Fanguo Meng, Quan He(Jiangsu University)
Cited by 0
Related Papers
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716
STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications
|Oncogene|2001|700
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors
|American Journal Of Pathology|2000|647
Primary Renal Neoplasms with the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma
|American Journal Of Pathology|2001|639